The lateral entry system in 2026 is a strategic academic "bridge" designed by the Pharmacy Council of India (PCI) to recognize the prior technical training of diploma holders. Under this provision, students who have successfully completed their two-year D.Pharm course are not required to start the four-year Bachelor of Pharmacy (B.Pharm) from the beginning. Instead, they are permitted to skip the first two semesters (the entire first year) and join the degree program directly in the second year (third semester). This effectively condenses the bachelor's degree into a three-year journey for these candidates, rewarding their previous laboratory and clinical experience.
To qualify for this advanced standing, a candidate must have passed their D.Pharm from an institution strictly approved by the PCI. The minimum requirement of 50% marks in the diploma serves as a quality benchmark, ensuring that the student has a strong enough grasp of pharmaceutical chemistry and pharmaceutics to handle the increased complexity of degree-level subjects. In the 2026 admission cycle, many top colleges in the Delhi NCR region, including Puran Murti Campus, use these marks to create a merit list, though some states may also require a lateral entry entrance test (LEET) to finalize seat allotment.
One of the most significant advantages for lateral entry students is their practical proficiency. Having already completed 500 hours of mandatory hospital training during their diploma, these students often enter the 3rd semester with superior hands-on skills compared to traditional students. While their peers spent the first year on general science foundations, lateral entry students have already handled real-world prescriptions and drug formulations. This clinical maturity allows them to excel in advanced 2026 modules like Pharmaceutical Microbiology and Physical Pharmaceutics, where practical application is as critical as theoretical understanding.
Financially and professionally, the lateral entry route offers an exceptional return on investment (ROI). By bypassing the first year of B.Pharma, students save a full year’s worth of tuition fees, hostel expenses, and library charges—an estimated saving of ₹1.2 lakh to ₹1.5 lakh depending on the 2026 fee structure. More importantly, it allows the student to enter the "Registered Pharmacist" job market or apply for the GPAT (for Master's studies) one year earlier. This head start is invaluable in a fast-paced healthcare economy that rewards specialized qualifications and early career entry.
Ultimately, the lateral entry program at Puran Murti Campus ensures vertical mobility for pharmacy professionals. It bridges the gap between being a pharmacy technician (D.Pharma) and becoming a pharmaceutical scientist or drug administrator (B.Pharma). For the 2026 session, this path remains the most popular choice for students who initially aimed for a quick diploma but later decided to pursue higher-ranking roles such as quality control manager or drug inspector, providing them with a clear, state-approved ladder to reach the highest echelons of the pharmaceutical industry.